Clinical Trials Logo

Clinical Trial Summary

It is estimated that spinal cord injury (SCI) affects approximately 12,000 new individuals every year in the United States, with the majority are cervical and/or upper thoracic injuries. Despite this high prevalence of obstructive sleep apnea (OSA) in chronic SCI population minority of patients are treated and are adherent to standard therapy (CPAP). This proposal addresses a new therapeutic intervention for OSA in SCI. The investigators hypothesized that combined oropharyngeal and respiratory muscle exercises improve respiratory symptoms and alleviate OSA in patients with chronic SCI. The investigators will perform a pilot randomized, sham-controlled study to examine the impact of combined daily exercises (~30 min) for 1 and 3 months durations among Veterans with SCI. The investigators believe that this novel approach to treating OSA and will yield significant new knowledge that improves the health and quality of life of these patients.


Clinical Trial Description

In recent years, the investigators and others have discovered that spinal cord injury/disease (SCI/D) is associated with significant increase in the sleep-disordered breathing (SDB) prevalence. Nearly 80% of patients with SCI/D including Veterans suffer from SDB after six months of injury (majority of them 70-80% are obstructive apneas and hypopneas-OSA). However, most patients SCI/D do not tolerate standard SDB treatment (continuous positive airway pressure-CPAP) leading to lack of compliance. Therefore, identifying other therapies is important for this common condition that is linked to poor outcome in the general population (heart disease, stroke, hypertension and poor cognition). It has been reported in sleep apnea able-bodied patients that oropharyngeal muscle exercises for 3 months using speech pathology techniques improve the severity of SDB. Furthermore, previous studies showed respiratory muscle training (RMT) is effective for increasing respiratory muscle strength in people with cervical SCI. However, the effect of combined oropharyngeal and RMT on OSA in patients with SCI is unknown. The purpose of this application is to identify new therapeutic interventions for OSA treatment in Veterans with SCI/D. This application proposes for a pilot study to randomizing 30 Veterans with SCI/D and OSA to receive 3 months of daily (30 minutes) treatment with a validated set of oropharyngeal and RMT (intervention arm) versus sham therapy (control arm). There will be three specific aims to address the following hypotheses: Specific Aim (1): To test recruitment rate and feasibility of a pilot intervention that includes combined oropharyngeal and RMT versus sham treatment in individuals with SCI/D. Specific Aim (2): To test the acceptability and usability of combined oropharyngeal and RMT in individuals with SCI/D. Specific Aim (3): To determine the effect size estimates for clinical endpoints and their associated variability at the end of treatment to calculate an appropriate sample size for an adequately powered clinical trial. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03664765
Study type Interventional
Source VA Office of Research and Development
Contact
Status Completed
Phase N/A
Start date January 1, 2019
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Completed NCT05404438 - Mouth Breathing Habits Improvement Intervention N/A
Recruiting NCT05960175 - Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP N/A
Recruiting NCT05813275 - Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) Phase 3
Completed NCT05075668 - Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA N/A
Completed NCT05881512 - Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea N/A
Completed NCT03336515 - Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural) N/A
Not yet recruiting NCT05944965 - Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT02387476 - Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea N/A
Not yet recruiting NCT06058052 - Prevalence of OSA in Patients of ILD
Recruiting NCT03721445 - Could HRV be a Valuable Predictor for CPAP Adherence?
Completed NCT03172130 - Sham CPAP vs. Straight CPAP for Chronic Cough N/A
Recruiting NCT06320795 - Prospective Study for the Clinical Validation of the Soundi Wearable Medical Device N/A
Completed NCT01717339 - Sleep Apnea and Vascular Function N/A
Completed NCT00772044 - Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea Phase 4
Completed NCT02438137 - Dimethyl Fumarate for Obstructive Sleep Apnea N/A
Completed NCT01672606 - Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea N/A
Not yet recruiting NCT06110962 - Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor
Not yet recruiting NCT06400615 - Study That Tests AD109 in Patients Taking GLP-1 Drugs Phase 2
Completed NCT05060133 - Changes of the Upper Airway Volume After Orthognathic Surgery
Completed NCT03196583 - Efficacy of a Novel MAD in OSA N/A